As of 2025-09-15, the Intrinsic Value of Replimune Group Inc (REPL) is -17.95 USD. This REPL valuation is based on the model Peter Lynch Fair Value. With the current market price of 5.73 USD, the upside of Replimune Group Inc is -413.24%.
Based on its market price of 5.73 USD and our intrinsic valuation, Replimune Group Inc (REPL) is overvalued by 413.24%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -17.95 - -17.95 | -17.95 | -413.24% |
| P/E | (95.85) - (96.13) | (97.82) | -1807.2% |
| DDM - Stable | (29.55) - (81.24) | (55.40) | -1066.8% |
| DDM - Multi | (23.07) - (49.95) | (31.64) | -652.1% |
| Market Cap (mil) | 447.28 |
| Beta | 0.18 |
| Outstanding shares (mil) | 78.06 |
| Enterprise Value (mil) | 422.06 |
| Market risk premium | 4.60% |
| Cost of Equity | 10.24% |
| Cost of Debt | 5.00% |
| WACC | 9.51% |